Lyngso; Lars Ole

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lyngso; Lars Ole.The latest application filed is for "5,8-dimethyl-2-[2-(1-methyl-4-phenyl-1h-imidazol-2-yl)-ethyl]-[1,2,4]triaz- olo[1,5-a]pyrazine hemiadipate".

Company Profile

0.5.6

Lyngso; Lars Ole - Vekso Sj. DK

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
5,8-dimethyl-2-[2-(1-methyl-4-phenyl-1h-imidazol-2-yl)-ethyl]-[1,2,4]triaz- Olo[1,5-a]pyrazine Hemiadipate App 20200140446 - Jensen; Anette Frost ; et al.	2020-05-07
Processes for 4-((1R,35)-6-Chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine or a salt thereof Grant 8,227,607 - de Diego , et al. July 24, 2	2012-07-24
Malonate salt of 4-((1R,3S)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and uses of same Grant 8,076,342 - Lopez de Diego , et al. December 13, 2	2011-12-13
Malonate Salt Of 4-((1r,3s)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine And Uses Of Same App 20110053957 - Lopez de Diego; Heidi ; et al.	2011-03-03
Processes For 4-((1r,3s)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine Or A Salt Thereof App 20100324291 - Lopez de Diego; Heidi ; et al.	2010-12-23
Trans-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine Grant 7,772,240 - Bang-Andersen , et al. August 10, 2	2010-08-10
Hydrogen succinate salts of trans-4-((1R, 3S)-6-chloro-3-phenylindan-1-YL)-1,2,2-trimethylpiperazine and the use as a medicament Grant 7,767,683 - Lopez de Diego , et al. August 3, 2	2010-08-03
Method for the separation of intermediates which may be used for the preparation of escitalopram Grant 7,582,780 - Lyngso September 1, 2	2009-09-01
Method for the separation of intermediates which may be used for the preparation of escitalopram App 20070190624 - Lyngso; Lars Ole	2007-08-16
Succinate and malonate salt of trans 4-(ir,3s)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and the use as a medicament App 20060281759 - de Diego; Heidi Lopez ; et al.	2006-12-14
Trans-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine App 20060281758 - Bang-Andersen; Benny ; et al.	2006-12-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.